HomeNewsBusinessSIDBI extends loan repayment term to 1-year for NBFCs, MFIs

SIDBI extends loan repayment term to 1-year for NBFCs, MFIs

This is a significant development as microlenders felt the earlier repayment rules were stringent considering the present operating environment.

April 29, 2020 / 15:44 IST
Story continues below Advertisement

Small Industries Development Bank of India (SIDBI) has extended the repayment period of loans to non-banking finance companies (NBFCs) and Microfinance Institutions (MFIs), announced under Reserve Bank of India's (RBI) special liquidity scheme, to one year from the 90-day period earlier.

This is a significant development  as microlenders felt the earlier repayment rules were stringent considering the present operating environment. Due to COVID-19 induced lockdown, operations of these firms have come to a halt. Most MFIs and NBFCs felt that they wwill not have enough time to make repayments to SIDBI in just 90 days.

Story continues below Advertisement

MFIs are companies that typically lend to low-income borrowers, who are mostly daily-wage earners or run microbusinesses. These loans are given for 18-24 months at a rate of 21-23 percent. The average loan ticket size is around Rs 30,000.

Under the special liquidity measures announced by the Reserve Bank of India (RBI) to fight Covid-19, the central bank had given Rs 15,000 crore to SIDBI. Subsequently, SIDBI had announced a scheme for these companies. While SIDBI has now relaxed the repayment timeframe, the rating requirement stays.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show